EP 1435958 A1 20040714 - USE OF PHOSPHORODIESTERASE IV INHIBITORS
Title (en)
USE OF PHOSPHORODIESTERASE IV INHIBITORS
Title (de)
VERWENDUNG VON PHOSPHODIESTERASE IV - INHIBITOREN
Title (fr)
UTILISATION D'INHIBITEURS DE LA PHOSPHODIESTERASE IV
Publication
Application
Priority
- DE 10150517 A 20011012
- EP 0210507 W 20020919
Abstract (en)
[origin: US2004235845A1] Use of phosphodiesterase IV inhibitors and/or physiologically acceptable salts thereof for the preparation of a medicament for the treatment of osteoporosis, tumours, tumour metastases, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, ulcerative collitis and AIDS.
IPC 1-7
A61K 31/50; A61K 31/54; A61K 31/535; A61P 19/10; A61P 35/00; A61P 37/00; A61P 3/10
IPC 8 full level
C07D 237/04 (2006.01); A61K 31/50 (2006.01); A61K 31/501 (2006.01); A61K 31/535 (2006.01); A61K 31/5395 (2006.01); A61K 31/54 (2006.01); A61K 31/549 (2006.01); A61P 1/04 (2006.01); A61P 3/10 (2006.01); A61P 9/10 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 25/00 (2006.01); A61P 29/00 (2006.01); A61P 31/18 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); A61P 37/00 (2006.01); A61P 43/00 (2006.01); C07D 285/16 (2006.01); C07D 401/12 (2006.01); C07D 411/12 (2006.01); C07D 413/12 (2006.01)
CPC (source: EP KR US)
A61K 31/50 (2013.01 - EP US); A61K 31/501 (2013.01 - KR); A61K 31/535 (2013.01 - EP US); A61K 31/54 (2013.01 - EP US); A61P 1/04 (2017.12 - EP); A61P 3/08 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 31/18 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/04 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 03032993A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
US 2004235845 A1 20041125; AR 037741 A1 20041201; AU 2002338734 B2 20071108; CA 2460135 A1 20030424; CA 2460135 C 20100824; CN 1564687 A 20050112; CZ 2004457 A3 20050413; DE 10150517 A1 20030417; EP 1435958 A1 20040714; HU P0401641 A2 20041129; HU P0401641 A3 20070228; JP 2005505604 A 20050224; KR 20050028900 A 20050323; MX PA04002639 A 20040607; NO 20041938 L 20040511; SK 1652004 A3 20050505; WO 03032993 A1 20030424
DOCDB simple family (application)
US 49236704 A 20040412; AR P020103824 A 20021011; AU 2002338734 A 20020919; CA 2460135 A 20020919; CN 02819863 A 20020919; CZ 2004457 A 20020919; DE 10150517 A 20011012; EP 0210507 W 20020919; EP 02777150 A 20020919; HU P0401641 A 20020919; JP 2003535796 A 20020919; KR 20047005415 A 20040412; MX PA04002639 A 20020919; NO 20041938 A 20040511; SK 1652004 A 20020919